Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
James Burton, DM, FRCP
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Current FSGS Treatment Landscape: More Questions Than Answers
Vladimir Tesar
Meghan Sise, MD
FSGS: When Solutions Fall Short
FSGS: Interpretation of Proteinuria Reduction Thresholds
Future Directions in FSGS Care
Kenneth Lieberman, MD
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Raman Sankar, MD, PhD
Scott Aaronson, MD
Epilepsy: Beyond Seizure Impact
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Don't Miss It! Rapid & Accurate AAV Diagnosis
Andreas Kronbichler, MD
Managing Patients With AAV in the Rheumatology Clinic
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Tailoring Treatment for Optimal Outcomes in Patients With AAV